1-7 of 7
Wanxing Chai-Ho
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination with Azacitidine in Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes (AK117-205)

Amer M. Zeidan, Hongyan Tong, Zhijian Xiao, Praneeth Baratam, Ramzi Abboud, Christopher B. Benton, Joshua F Zeidner, Uma Borate, Wanxing Chai-Ho, Yonglin Lu, Jie Yang, Mingxiu Hu, Baiyong Li, Michelle Xia, David Sallman
Journal: Blood
Blood (2024) 144 (Supplement 1): 6705.
https://doi.org/10.1182/blood-2024-200541
Published: 2024
Journal Articles

Reconsidering the Significance of Blast Cut-Offs in Differentiating between MDS and AML Biology

Helen Shang, Claire Daniel, Michael J. Maranzano, Sarah Stettner, Daria Louise Gaut, Sophie Carlson, Yash Motwani, Alexandra M. Klomhaus, Caspian H. Oliai, Gary J. Schiller, Wanxing Chai-Ho
Journal: Blood
Blood (2023) 142 (Supplement 1): 1884.
https://doi.org/10.1182/blood-2023-189790
Published: 2023
Journal Articles

Safety, Pharmacodynamic, and Anti-Tumor Activity of SL-172154 As Monotherapy and in Combination with Azacitidine (AZA) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) Patients (pts)

Naval Daver, Anthony Selwyn Stein, Dale Bixby, Wanxing Chai-Ho, Joshua F. Zeidner, Keri Maher, Don A. Stevens, Maximilian Stahl, Karen Yee, Emily K Curran, Sawa Ito, Andrew Sochacki, David A Sallman, Robert Hernandez, Simon Metenou, Bo Ma, Kazunobu Kato, Amer M. Zeidan
Journal: Blood
Blood (2023) 142 (Supplement 1): 4278.
https://doi.org/10.1182/blood-2023-173991
Published: 2023
Journal Articles

Real-World Safety and Health Care Resource Utilization Analysis of Venetoclax and Hypomethylating-Agent Treatment for AML in an Academic-Affiliated Urban Community Oncology Network

Sophie G Carlson, Jonathan Boiarsky, Claire E. Daniel, Daria Gaut, Catherine Cascavita, Christine Lam, Michael Doyel, Gary J. Schiller, Wanxing Chai-Ho
Journal: Blood
Blood (2022) 140 (Supplement 1): 13282–13284.
https://doi.org/10.1182/blood-2022-165447
Published: 2022
Journal Articles

The Trend of Respiratory Virus Infection in Allogeneic Bone Marrow Transplant Recipients during the COVID Pandemic

Guneet Kaleka, John Sharp, Kailyn Kim, Pryce Gaynor, Gary J. Schiller, Wanxing Chai-Ho
Journal: Blood
Blood (2022) 140 (Supplement 1): 5096–5097.
https://doi.org/10.1182/blood-2022-167773
Published: 2022
Journal Articles

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Clinical Trials & Observations
Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aleksandr Lazaryan, Aravind Ramakrishnan, Zachariah DeFilipp, Amandeep Salhotra, Wanxing Chai-Ho, Rohtesh Mehta, Trent Wang, Mukta Arora, Iskra Pusic, Ayman Saad, Nirav N. Shah, Sunil Abhyankar, Carlos Bachier, John Galvin, Annie Im, Amelia Langston, Jane Liesveld, Mark Juckett, Aaron Logan, Levanto Schachter, Asif Alavi, Dianna Howard, Harlan W. Waksal, John Ryan, David Eiznhamer, Sanjay K. Aggarwal, Jonathan Ieyoub, Olivier Schueller, Laurie Green, Zhongming Yang, Heidi Krenz, Madan Jagasia, Bruce R. Blazar, Steven Pavletic
Journal: Blood
Blood (2021) 138 (22): 2278–2289.
https://doi.org/10.1182/blood.2021012021
Published: 2021
Includes: Supplemental data
Journal Articles

Grb10 Is a Tumor Suppressor in Human Acute Myeloid Leukemia

Wanxing Chai-Ho, MD, Martina M Roos, PhDPharmD, Michelle Li, Pang Amara, Yurun Zhang, Tiancheng Fang, Christina Termini, PhDBS, John P Chute, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1344.
https://doi.org/10.1182/blood-2018-99-110844
Published: 2018